Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.3085
-0.0059 (-1.88%)
Oct 2, 2026, 1:26 PM EDT - Market open
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $28.34 million as of October 2, 2026. Its market cap has decreased by -67.42% in one year.
Market Cap
28.34M
Enterprise Value
-14.40M
1-Year Change
-67.42%
Ranking
Category
Stock Price
$0.31
ChartMarket Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has decreased from $51.03M to $28.34M, a decrease of -44.45%. That is a compound annual growth rate of -11.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 28.34M | -79.01% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeyondSpring | 31.09M |
| aTyr Pharma | 30.90M |
| TransCode Therapeutics | 29.12M |
| Quantum BioPharma | 29.12M |
| IGC Pharma | 28.48M |
| Karyopharm Therapeutics | 28.35M |
| ABVC BioPharma | 27.29M |
| Evaxion | 27.27M |